8,326 Shares in Laboratory Co. of America Holdings (NYSE:LH) Purchased by Southeast Asset Advisors LLC

Southeast Asset Advisors LLC purchased a new position in Laboratory Co. of America Holdings (NYSE:LH - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 8,326 shares of the medical research company's stock, valued at approximately $1,909,000.

A number of other large investors have also modified their holdings of the stock. Graney & King LLC purchased a new position in Laboratory Co. of America in the fourth quarter worth approximately $26,000. Fortitude Family Office LLC lifted its position in shares of Laboratory Co. of America by 312.5% during the 4th quarter. Fortitude Family Office LLC now owns 132 shares of the medical research company's stock worth $30,000 after purchasing an additional 100 shares during the last quarter. Geneos Wealth Management Inc. grew its stake in shares of Laboratory Co. of America by 309.8% during the fourth quarter. Geneos Wealth Management Inc. now owns 168 shares of the medical research company's stock worth $39,000 after purchasing an additional 127 shares in the last quarter. Human Investing LLC acquired a new stake in Laboratory Co. of America in the fourth quarter valued at $39,000. Finally, Heck Capital Advisors LLC acquired a new position in shares of Laboratory Co. of America during the 4th quarter worth about $44,000. Hedge funds and other institutional investors own 95.94% of the company's stock.

Analysts Set New Price Targets

Several research firms recently weighed in on LH. Redburn Atlantic started coverage on Laboratory Co. of America in a research note on Wednesday, April 2nd. They set a "buy" rating and a $276.00 target price for the company. Jefferies Financial Group increased their target price on shares of Laboratory Co. of America from $275.00 to $290.00 and gave the company a "buy" rating in a research report on Thursday, February 6th. StockNews.com raised shares of Laboratory Co. of America from a "hold" rating to a "buy" rating in a research report on Sunday, April 6th. Piper Sandler raised their price objective on Laboratory Co. of America from $240.00 to $260.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Finally, Bank of America boosted their target price on Laboratory Co. of America from $262.00 to $271.00 and gave the company a "buy" rating in a report on Friday, December 13th. Three investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $268.77.

Remove Ads

Laboratory Co. of America Stock Performance

Shares of LH stock traded up $2.85 during midday trading on Friday, hitting $221.46. The company had a trading volume of 1,031,685 shares, compared to its average volume of 638,269. Laboratory Co. of America Holdings has a 52-week low of $191.97 and a 52-week high of $258.59. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.44 and a quick ratio of 1.30. The company's 50 day simple moving average is $240.04 and its 200 day simple moving average is $234.81. The stock has a market cap of $18.53 billion, a price-to-earnings ratio of 25.11, a PEG ratio of 1.71 and a beta of 0.99.

Laboratory Co. of America (NYSE:LH - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The medical research company reported $3.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.40 by $0.05. Laboratory Co. of America had a net margin of 5.73% and a return on equity of 15.29%. Research analysts anticipate that Laboratory Co. of America Holdings will post 16.01 earnings per share for the current fiscal year.

Laboratory Co. of America Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 11th. Investors of record on Thursday, May 29th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 1.30%. Laboratory Co. of America's payout ratio is currently 32.65%.

Insider Buying and Selling at Laboratory Co. of America

In related news, CMO Amy B. Summy sold 226 shares of the business's stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $250.40, for a total value of $56,590.40. Following the sale, the chief marketing officer now directly owns 4,544 shares in the company, valued at $1,137,817.60. The trade was a 4.74 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Der Vaart Sandra D. Van sold 1,314 shares of the firm's stock in a transaction dated Tuesday, February 25th. The shares were sold at an average price of $251.30, for a total transaction of $330,208.20. Following the transaction, the executive vice president now owns 2,171 shares of the company's stock, valued at $545,572.30. This trade represents a 37.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 14,258 shares of company stock valued at $3,518,177. 0.85% of the stock is owned by corporate insiders.

Laboratory Co. of America Profile

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.